Related Experiment Video
Updated: Apr 13, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Clinical characteristics of concomitant nephrotic IgA nephropathy and minimal change disease in children
Huijun Shen1, Weizhong Gu, Jianhua Mao
1Department of Nephrology, The Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Insights
IgA nephropathy (IgAN) can coexist with minimal change disease (MCD) in children. Most pediatric patients with this IgAN and MCD overlap, presenting with nephrotic syndrome, respond well to steroid treatment and show a favorable prognosis.
Area of Science:
- Pediatric Nephrology
- Glomerular Diseases
- Renal Pathology
Background:
- IgA nephropathy (IgAN) is the most common primary glomerulonephritis in children.
- Minimal change disease (MCD) is the leading cause of nephrotic syndrome in pediatric populations.
- Coexistence of IgAN and MCD has been reported in adults, but pediatric data are limited.
Purpose of the Study:
- To investigate the clinical and pathological features of IgA nephropathy (IgAN) complicated by minimal change disease (MCD) in children.
- To evaluate the treatment response and prognosis of pediatric patients with coexisting IgAN and MCD.
Main Methods:
- Retrospective analysis of 197 children diagnosed with IgAN between December 2007 and November 2013.
- Evaluation based on nephrotic syndrome criteria and MCD pathological features.
- Assessment of clinical manifestations, treatment, and follow-up data.
Main Results:
- Seven out of 197 (2.8%) IgAN patients presented with both MCD-like pathology and nephrotic syndrome.
- The affected cohort included 5 boys with a median age of 8.9 years.
- Six of the seven patients showed steroid sensitivity and achieved complete remission, indicating a favorable prognosis.
Conclusions:
- IgA nephropathy (IgAN) and minimal change disease (MCD) can occur concurrently in pediatric patients.
- Children with coexisting IgAN and MCD presenting with nephrotic syndrome generally respond well to corticosteroid therapy.
- Further large-scale studies are warranted to understand these complex cases better.
Background:
IgA nephropathy (IgAN) is the most common primary glomerulonephritis in children and adolescents worldwide. Meanwhile, minimal change disease (MCD) is the most common cause of nephrotic syndrome in children. Recently, several case reports have revealed that IgAN can be complicated by MCD in adults. Here, we report our experience concerning the features of such patients in pediatrics.
Methods:
The clinical manifestations and pathological features of 197 children who presented with IgAN from December 2007 to November 2013 were analyzed retrospectively based on the criteria for nephrotic syndrome and MCD.
Results:
Among the 197 children diagnosed with primary IgAN, 25 (12.7%) patients presented with nephrotic syndrome, and 7 patients (2.8%) presented with MCD-like pathological features and nephrotic syndrome simultaneously. The cohort of 7 patients included 5 boys, and the median age was 8.9. All of the patients who were diagnosed with primary nephrotic syndrome were treated initially with corticosteroids. Except for 1 patient with steroid resistance who was lost to follow-up, the other 6 cases presented were steroid sensitive and remained in complete remission for the last follow-up, with median and mean follow-up durations of 30.5 and 34.5 months, respectively (range 10-65 months).
Conclusions:
This study revealed that IgAN and MCD may also coexist in children. Moreover, most of these patients who presented with nephrotic syndrome responded well to steroids and had a favorable prognosis. Large-scale studies are required, and careful attention should be paid to such complicated cases.
More Related Videos
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Nephrons
Chronic Kidney Disease I: Introduction

